by Clinical Neuropsychologist Online | Sunday, October 6, 2024 | Dementia
Abstract Diagnosing Alzheimer’s disease (AD) poses significant challenges to health care, often resulting in delayed or inadequate patient care. The clinical integration of blood-based biomarkers (BBMs) for AD holds promise in enabling early detection of...
by Clinical Neuropsychologist Online | Sunday, October 6, 2024 | Dementia
Abstract INTRODUCTION We evaluated the efficacy and safety of brexpiprazole for the treatment of agitation in Alzheimer’s dementia (AAD) in Japanese patients. METHODS This was a phase 2/3 multicenter, randomized, double-blind, placebo-controlled, parallel-group...
by Clinical Neuropsychologist Online | Sunday, October 6, 2024 | Dementia
Alzheimer’s &Dementia, EarlyView. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: Nilton Custodio, Ricardo Allegri, Francisco Lopera, Paulo...
by Clinical Neuropsychologist Online | Sunday, October 6, 2024 | Dementia
Abstract INTRODUCTION People with neurodegenerative disorders (ND) frequently face diagnostic delay and misdiagnosis. We investigated blood and cerebrospinal fluid (CSF) neurofilament light chain (NfL) to distinguish ND from primary psychiatric disorders (PPD), a...
by Clinical Neuropsychologist Online | Sunday, October 6, 2024 | Dementia
Abstract The Alzheimer’s Disease Neuroimaging Initiative (ADNI) has fostered collaboration among researchers around the world, catalyzing innovation and accelerating progress in the field. In Latin America, this initiative advanced the validation and development...
